Form 4: Weyco Group Chairman Acquires Shares Through Family Trust, Reports Beneficial Ownership Changes
SEC Form 4
Thomas W. Florsheim Jr., Chairman and CEO of Weyco Group, reports changes in beneficial ownership, including the acquisition of shares through a family trust and holdings by his wife and children's trusts.
Summary
- Thomas W. Florsheim Jr., Chairman and CEO of Weyco Group, filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
- On October 2, 2024, Florsheim acquired 40,250 shares of Common Stock at $0 through a transaction coded 'J'.
- Following the transaction, Florsheim directly owns 221,873 shares as trustee of the John Florsheim Family Trust.
- He also indirectly owns 801,144 shares, 52,113 shares through his wife, 268,779 shares as trustee for his children, and 94,619 shares held in a 2018 Irrevocable Trust.
- Florsheim also holds multiple stock options with varying exercise prices and expiration dates, totaling 67,000 shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing simply reports changes in beneficial ownership, which can be interpreted in various ways depending on the investor's perspective. The acquisition of shares by the CEO could be seen as a positive sign, but it's not definitively bullish.
Positives
- The acquisition of shares by the Chairman and CEO could be interpreted as a sign of confidence in the company's future prospects.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. Investors often monitor these filings for signals about management's perspective on the company's value and future prospects.
Stakeholder Impact
- The reported changes in beneficial ownership may influence investor sentiment and potentially affect the company's stock price.
Key Dates
| Date | Description |
|---|---|
| 08/25/2018 | First stock option grant exercisable date |
| 08/23/2019 | Second stock option grant exercisable date |
| 08/14/2020 | Third stock option grant exercisable date |
| 08/26/2021 | Fourth stock option grant exercisable date |
| 08/25/2022 | Fifth stock option grant exercisable date |
| 08/25/2023 | Sixth stock option grant exercisable date |
| 08/25/2024 | Seventh stock option grant exercisable date and date of transaction |
| 08/25/2027 | First stock option grant expiration date |
| 08/23/2028 | Second stock option grant expiration date |
| 08/14/2029 | Third stock option grant expiration date |
| 08/26/2030 | Fourth stock option grant expiration date |
| 08/25/2031 | Fifth stock option grant expiration date |
| 08/25/2032 | Sixth stock option grant expiration date |
| 08/25/2033 | Seventh stock option grant expiration date |
| 10/02/2024 | Date of transaction |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.